ID WDR43_HUMAN Reviewed; 677 AA. AC Q15061; Q15395; Q92577; DT 27-SEP-2004, integrated into UniProtKB/Swiss-Prot. DT 24-JUL-2007, sequence version 3. DT 24-JAN-2024, entry version 189. DE RecName: Full=WD repeat-containing protein 43; DE AltName: Full=U3 small nucleolar RNA-associated protein 5 homolog; GN Name=WDR43 {ECO:0000312|HGNC:HGNC:28945}; Synonyms=KIAA0007, UTP5; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Bone marrow; RX PubMed=7584026; DOI=10.1093/dnares/1.1.27; RA Nomura N., Miyajima N., Sazuka T., Tanaka A., Kawarabayasi Y., Sato S., RA Nagase T., Seki N., Ishikawa K., Tabata S.; RT "Prediction of the coding sequences of unidentified human genes. I. The RT coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of RT randomly sampled cDNA clones from human immature myeloid cell line KG-1."; RL DNA Res. 1:27-35(1994). RN [2] RP SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=12429849; DOI=10.1091/mbc.e02-05-0271; RA Scherl A., Coute Y., Deon C., Calle A., Kindbeiter K., Sanchez J.-C., RA Greco A., Hochstrasser D.F., Diaz J.-J.; RT "Functional proteomic analysis of human nucleolus."; RL Mol. Biol. Cell 13:4100-4109(2002). RN [3] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-77, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=17081983; DOI=10.1016/j.cell.2006.09.026; RA Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.; RT "Global, in vivo, and site-specific phosphorylation dynamics in signaling RT networks."; RL Cell 127:635-648(2006). RN [4] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-431, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=16964243; DOI=10.1038/nbt1240; RA Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; RT "A probability-based approach for high-throughput protein phosphorylation RT analysis and site localization."; RL Nat. Biotechnol. 24:1285-1292(2006). RN [5] RP FUNCTION, AND SUBUNIT. RX PubMed=17699751; DOI=10.1101/gad.436707; RA Prieto J.L., McStay B.; RT "Recruitment of factors linking transcription and processing of pre-rRNA to RT NOR chromatin is UBF-dependent and occurs independent of transcription in RT human cells."; RL Genes Dev. 21:2041-2054(2007). RN [6] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-431, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=18669648; DOI=10.1073/pnas.0805139105; RA Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., RA Elledge S.J., Gygi S.P.; RT "A quantitative atlas of mitotic phosphorylation."; RL Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). RN [7] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-77; THR-394; SER-399; RP SER-431; THR-656 AND SER-658, AND IDENTIFICATION BY MASS SPECTROMETRY RP [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=20068231; DOI=10.1126/scisignal.2000475; RA Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., RA Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.; RT "Quantitative phosphoproteomics reveals widespread full phosphorylation RT site occupancy during mitosis."; RL Sci. Signal. 3:RA3-RA3(2010). RN [8] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [9] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-77; SER-431; SER-437; RP SER-590; THR-656 AND SER-658, AND IDENTIFICATION BY MASS SPECTROMETRY RP [LARGE SCALE ANALYSIS]. RX PubMed=21406692; DOI=10.1126/scisignal.2001570; RA Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., RA Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.; RT "System-wide temporal characterization of the proteome and phosphoproteome RT of human embryonic stem cell differentiation."; RL Sci. Signal. 4:RS3-RS3(2011). RN [10] RP POSSIBLE ASSOCIATION IN THE SSU PROCESSOME T-UTP SUBCOMPLEX. RX PubMed=22916032; DOI=10.1371/journal.pgen.1002892; RA Freed E.F., Prieto J.L., McCann K.L., McStay B., Baserga S.J.; RT "NOL11, implicated in the pathogenesis of North American Indian childhood RT cirrhosis, is required for pre-rRNA transcription and processing."; RL PLoS Genet. 8:E1002892-E1002892(2012). RN [11] RP SUBCELLULAR LOCATION, AND INTERACTION WITH UTP4 AND UTP15. RX PubMed=24219289; DOI=10.1139/bcb-2013-0062; RA Sato M., Araki N., Kumeta M., Takeyasu K., Taguchi Y., Asai T., RA Furukawa K., Horigome T.; RT "Interaction, mobility, and phosphorylation of human orthologues of WD RT repeat-containing components of the yeast SSU processome t-UTP sub- RT complex."; RL Biochem. Cell Biol. 91:466-475(2013). RN [12] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-321; THR-394 AND SER-431, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma, and Erythroleukemia; RX PubMed=23186163; DOI=10.1021/pr300630k; RA Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J., RA Mohammed S.; RT "Toward a comprehensive characterization of a human cancer cell RT phosphoproteome."; RL J. Proteome Res. 12:260-271(2013). RN [13] RP SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-309 AND LYS-384, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=25114211; DOI=10.1073/pnas.1413825111; RA Impens F., Radoshevich L., Cossart P., Ribet D.; RT "Mapping of SUMO sites and analysis of SUMOylation changes induced by RT external stimuli."; RL Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014). RN [14] RP SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-309 AND LYS-384, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=28112733; DOI=10.1038/nsmb.3366; RA Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C., RA Nielsen M.L.; RT "Site-specific mapping of the human SUMO proteome reveals co-modification RT with phosphorylation."; RL Nat. Struct. Mol. Biol. 24:325-336(2017). RN [15] RP FUNCTION, RNA-BINDING, AND DEVELOPMENTAL STAGE. RX PubMed=31128943; DOI=10.1016/j.molcel.2019.05.007; RA Bi X., Xu Y., Li T., Li X., Li W., Shao W., Wang K., Zhan G., Wu Z., RA Liu W., Lu J.Y., Wang L., Zhao J., Wu J., Na J., Li G., Li P., Shen X.; RT "RNA Targets Ribogenesis Factor WDR43 to Chromatin for Transcription and RT Pluripotency Control."; RL Mol. Cell 0:0-0(2019). RN [16] {ECO:0007744|PDB:7MQ8, ECO:0007744|PDB:7MQ9, ECO:0007744|PDB:7MQA} RP STRUCTURE BY ELECTRON MICROSCOPY (2.70 ANGSTROMS), FUNCTION, SUBUNIT, AND RP SUBCELLULAR LOCATION. RX PubMed=34516797; DOI=10.1126/science.abj5338; RA Singh S., Vanden Broeck A., Miller L., Chaker-Margot M., Klinge S.; RT "Nucleolar maturation of the human small subunit processome."; RL Science 373:eabj5338-eabj5338(2021). CC -!- FUNCTION: Ribosome biogenesis factor that coordinates hyperactive CC transcription and ribogenesis (PubMed:17699751). Part of the small CC subunit (SSU) processome, first precursor of the small eukaryotic CC ribosomal subunit. During the assembly of the SSU processome in the CC nucleolus, many ribosome biogenesis factors, an RNA chaperone and CC ribosomal proteins associate with the nascent pre-rRNA and work in CC concert to generate RNA folding, modifications, rearrangements and CC cleavage as well as targeted degradation of pre-ribosomal RNA by the CC RNA exosome. Involved in nucleolar processing of pre-18S ribosomal RNA. CC Required for optimal pre-ribosomal RNA transcription by RNA polymerase CC I (PubMed:17699751, PubMed:34516797). Essential for stem cell CC pluripotency and embryonic development. In the nucleoplasm, recruited CC by promoter-associated/nascent transcripts and transcription to active CC promoters where it facilitates releases of elongation factor P-TEFb and CC paused RNA polymerase II to allow transcription elongation and maintain CC high-level expression of its targets genes (By similarity). CC {ECO:0000250|UniProtKB:Q6ZQL4, ECO:0000269|PubMed:17699751, CC ECO:0000269|PubMed:34516797}. CC -!- SUBUNIT: Part of the small subunit (SSU) processome, composed of more CC than 70 proteins and the RNA chaperone small nucleolar RNA (snoRNA) U3 CC (PubMed:34516797). May be a component of the proposed t-UTP subcomplex CC of the ribosomal small subunit (SSU) processome containing at least CC UTP4, WDR43, HEATR1, UTP15, WDR75 (PubMed:17699751, PubMed:22916032). CC Binds to RNA; binding is required for its chromatin association. CC Interacts with CDK9, DDX21 and SUPT6H. Interacts with RNA polymerase II CC (By similarity). Interacts directly with UTP4 and UTP15 CC (PubMed:24219289). {ECO:0000250|UniProtKB:Q6ZQL4, CC ECO:0000269|PubMed:24219289, ECO:0000269|PubMed:34516797, CC ECO:0000305|PubMed:17699751, ECO:0000305|PubMed:22916032}. CC -!- INTERACTION: CC Q15061; Q969X6: UTP4; NbExp=3; IntAct=EBI-2563523, EBI-2602591; CC -!- SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:12429849, CC ECO:0000269|PubMed:24219289, ECO:0000269|PubMed:34516797}. Nucleus, CC nucleolus fibrillar center {ECO:0000269|PubMed:24219289}. Nucleus, CC nucleoplasm {ECO:0000250|UniProtKB:Q6ZQL4}. CC -!- DEVELOPMENTAL STAGE: Expressed during embryonic development, expression CC decreases at blastocyst stage. {ECO:0000269|PubMed:31128943}. CC -!- DOMAIN: N-terminal domain is required for nucleoplasm location and C- CC terminal domain for nucleolus location. {ECO:0000250|UniProtKB:Q6ZQL4}. CC -!- SIMILARITY: Belongs to the UTP5 family. {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=BAA05499.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; CC Sequence=BAA05499.1; Type=Frameshift; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; D26488; BAA05499.1; ALT_INIT; mRNA. DR EMBL; D87716; BAA13441.1; ALT_FRAME; mRNA. DR CCDS; CCDS46251.1; -. DR RefSeq; NP_055946.1; NM_015131.2. DR PDB; 7MQ8; EM; 3.60 A; LK/LL=1-677. DR PDB; 7MQ9; EM; 3.87 A; LK/LL=1-677. DR PDB; 7MQA; EM; 2.70 A; LK/LL=1-677. DR PDBsum; 7MQ8; -. DR PDBsum; 7MQ9; -. DR PDBsum; 7MQA; -. DR AlphaFoldDB; Q15061; -. DR EMDB; EMD-23936; -. DR EMDB; EMD-23937; -. DR EMDB; EMD-23938; -. DR SMR; Q15061; -. DR BioGRID; 116772; 124. DR ComplexPortal; CPX-2450; UTP-A complex. DR IntAct; Q15061; 24. DR MINT; Q15061; -. DR STRING; 9606.ENSP00000384302; -. DR GlyCosmos; Q15061; 1 site, 1 glycan. DR GlyGen; Q15061; 2 sites, 1 N-linked glycan (1 site), 1 O-linked glycan (1 site). DR iPTMnet; Q15061; -. DR PhosphoSitePlus; Q15061; -. DR SwissPalm; Q15061; -. DR BioMuta; WDR43; -. DR DMDM; 158518532; -. DR SWISS-2DPAGE; Q15061; -. DR EPD; Q15061; -. DR jPOST; Q15061; -. DR MassIVE; Q15061; -. DR MaxQB; Q15061; -. DR PaxDb; 9606-ENSP00000384302; -. DR PeptideAtlas; Q15061; -. DR ProteomicsDB; 60416; -. DR Pumba; Q15061; -. DR Antibodypedia; 51059; 82 antibodies from 15 providers. DR DNASU; 23160; -. DR Ensembl; ENST00000407426.8; ENSP00000384302.3; ENSG00000163811.12. DR GeneID; 23160; -. DR KEGG; hsa:23160; -. DR MANE-Select; ENST00000407426.8; ENSP00000384302.3; NM_015131.3; NP_055946.1. DR UCSC; uc002rmo.3; human. DR AGR; HGNC:28945; -. DR CTD; 23160; -. DR DisGeNET; 23160; -. DR GeneCards; WDR43; -. DR HGNC; HGNC:28945; WDR43. DR HPA; ENSG00000163811; Low tissue specificity. DR MIM; 616195; gene. DR neXtProt; NX_Q15061; -. DR OpenTargets; ENSG00000163811; -. DR PharmGKB; PA134914163; -. DR VEuPathDB; HostDB:ENSG00000163811; -. DR eggNOG; KOG4547; Eukaryota. DR GeneTree; ENSGT00390000004254; -. DR HOGENOM; CLU_020516_1_0_1; -. DR InParanoid; Q15061; -. DR OMA; KRNADNH; -. DR OrthoDB; 2248318at2759; -. DR PhylomeDB; Q15061; -. DR TreeFam; TF313160; -. DR PathwayCommons; Q15061; -. DR Reactome; R-HSA-6790901; rRNA modification in the nucleus and cytosol. DR Reactome; R-HSA-6791226; Major pathway of rRNA processing in the nucleolus and cytosol. DR SignaLink; Q15061; -. DR BioGRID-ORCS; 23160; 851 hits in 1165 CRISPR screens. DR ChiTaRS; WDR43; human. DR GenomeRNAi; 23160; -. DR Pharos; Q15061; Tbio. DR PRO; PR:Q15061; -. DR Proteomes; UP000005640; Chromosome 2. DR RNAct; Q15061; Protein. DR Bgee; ENSG00000163811; Expressed in buccal mucosa cell and 203 other cell types or tissues. DR ExpressionAtlas; Q15061; baseline and differential. DR Genevisible; Q15061; HS. DR GO; GO:0000785; C:chromatin; ISS:UniProtKB. DR GO; GO:0001650; C:fibrillar center; IDA:UniProtKB. DR GO; GO:0005730; C:nucleolus; IDA:UniProtKB. DR GO; GO:0005654; C:nucleoplasm; ISS:UniProtKB. DR GO; GO:0032040; C:small-subunit processome; IDA:UniProtKB. DR GO; GO:0003723; F:RNA binding; HDA:UniProtKB. DR GO; GO:0000993; F:RNA polymerase II complex binding; ISS:UniProtKB. DR GO; GO:0003711; F:transcription elongation factor activity; ISS:UniProtKB. DR GO; GO:0000462; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); IBA:GO_Central. DR GO; GO:2000234; P:positive regulation of rRNA processing; IMP:UniProtKB. DR GO; GO:0045943; P:positive regulation of transcription by RNA polymerase I; IMP:UniProtKB. DR GO; GO:2000036; P:regulation of stem cell population maintenance; ISS:UniProtKB. DR GO; GO:0034243; P:regulation of transcription elongation by RNA polymerase II; ISS:UniProtKB. DR GO; GO:0042274; P:ribosomal small subunit biogenesis; IDA:UniProtKB. DR Gene3D; 2.130.10.10; YVTN repeat-like/Quinoprotein amine dehydrogenase; 2. DR InterPro; IPR007148; SSU_processome_Utp12. DR InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf. DR InterPro; IPR036322; WD40_repeat_dom_sf. DR InterPro; IPR001680; WD40_rpt. DR PANTHER; PTHR44267; WD REPEAT-CONTAINING PROTEIN 43; 1. DR PANTHER; PTHR44267:SF1; WD REPEAT-CONTAINING PROTEIN 43; 1. DR Pfam; PF04003; Utp12; 1. DR Pfam; PF00400; WD40; 2. DR SMART; SM00320; WD40; 5. DR SUPFAM; SSF50978; WD40 repeat-like; 1. DR PROSITE; PS50082; WD_REPEATS_2; 1. DR PROSITE; PS50294; WD_REPEATS_REGION; 1. PE 1: Evidence at protein level; KW 3D-structure; Isopeptide bond; Nucleus; Phosphoprotein; Reference proteome; KW Repeat; Ribosome biogenesis; RNA-binding; rRNA processing; Transcription; KW Transcription regulation; Ubl conjugation; WD repeat. FT CHAIN 1..677 FT /note="WD repeat-containing protein 43" FT /id="PRO_0000051392" FT REPEAT 11..51 FT /note="WD 1" FT REPEAT 57..119 FT /note="WD 2" FT REPEAT 124..163 FT /note="WD 3" FT REPEAT 166..205 FT /note="WD 4" FT REPEAT 207..259 FT /note="WD 5" FT REPEAT 267..309 FT /note="WD 6" FT REGION 414..445 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 582..677 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 428..445 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 602..649 FT /note="Acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 650..667 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 77 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:17081983, FT ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692" FT MOD_RES 321 FT /note="Phosphothreonine" FT /evidence="ECO:0007744|PubMed:23186163" FT MOD_RES 394 FT /note="Phosphothreonine" FT /evidence="ECO:0007744|PubMed:20068231, FT ECO:0007744|PubMed:23186163" FT MOD_RES 399 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:20068231" FT MOD_RES 431 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:16964243, FT ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:20068231, FT ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163" FT MOD_RES 437 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21406692" FT MOD_RES 590 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21406692" FT MOD_RES 656 FT /note="Phosphothreonine" FT /evidence="ECO:0007744|PubMed:20068231, FT ECO:0007744|PubMed:21406692" FT MOD_RES 658 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:20068231, FT ECO:0007744|PubMed:21406692" FT CROSSLNK 309 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO1); alternate" FT /evidence="ECO:0007744|PubMed:25114211" FT CROSSLNK 309 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2); alternate" FT /evidence="ECO:0007744|PubMed:28112733" FT CROSSLNK 384 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO1); alternate" FT /evidence="ECO:0007744|PubMed:25114211" FT CROSSLNK 384 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2); alternate" FT /evidence="ECO:0007744|PubMed:28112733" SQ SEQUENCE 677 AA; 74891 MW; 4EEAD92C30118ACD CRC64; MAAGGGGSCD PLAPAGVPCA FSPHSQAYFA LASTDGHLRV WETANNRLHQ EYVPSAHLSG TCTCLAWAPA RLQAKESPQR KKRKSEAVGM SNQTDLLALG TAVGSILLYS TVKGELHSKL ISGGHDNRVN CIQWHQDSGC LYSCSDDKHI VEWNVQTCKV KCKWKGDNSS VSSLCISPDG KMLLSAGRTI KLWVLETKEV YRHFTGHATP VSSLMFTTIR PPNESQPFDG ITGLYFLSGA VHDRLLNVWQ VRSENKEKSA VMSFTVTDEP VYIDLTLSEN KEEPVKLAVV CRDGQVHLFE HILNGYCKKP LTSNCTIQIA TPGKGKKSTP KPIPILAAGF CSDKMSLLLV YGSWFQPTIE RVALNSREPH MCLVRDISNC WAPKVETAIT KVRTPVMNSE AKVLVPGIPG HHAAIKPAPP QTEQVESKRK SGGNEVSIEE RLGAMDIDTH KKGKEDLQTN SFPVLLTQGL ESNDFEMLNK VLQTRNVNLI KKTVLRMPLH TIIPLLQELT KRLQGHPNSA VLMVQWLKCV LTVHASYLST LPDLVPQLGT LYQLMESRVK TFQKLSHLHG KLILLITQVT ASEKTKGATS PGQKAKLVYE EESSEEESDD EIADKDSEDN WDEDEEESES EKDEDVEEED EDAEGKDEEN GEDRDTASEK ELNGDSDLDP ENESEEE //